67 results
8-K
EX-99.1
ARCT
Arcturus Therapeutics Holdings Inc
7 Mar 24
Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progress
4:05pm
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued liabilities
Current portion of long-term debt
Deferred revenue
Total
8-K
EX-99.1
isu8qdaiza03lmptd3
14 Nov 23
Arcturus Therapeutics Announces Third Quarter 2023 Financial Update
4:10pm
8-K
EX-99.1
by7yu77mxqx05fd6
7 Aug 23
Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress
4:23pm
8-K
EX-99.1
b54n o41w6
9 May 23
Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress
4:11pm
8-K
mmw9qy1y
13 Dec 22
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
4:14pm
8-K
EX-99.1
31lbcytswfdc79rdwqgc
13 Dec 22
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
4:14pm
8-K
EX-99.1
cjdgcqmwwmr
9 Nov 22
Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress
4:06pm
8-K
EX-99.1
bw96fp4bie9kio9nx9w
9 Aug 22
Arcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline Progress
12:00am